Need Help? Talk to an Expert +1 (408) 836-7136

Home

>

ipos-overview

Ipos overview

Pioneer Acquisition I Corp (PACHU)


Company Overview

Proposed Symbol PACHU
Company Name Pioneer Acquisition I Corp
Exchange NASDAQ Global
Share Price $10.00
Employees 1 (as of 06/20/2025)
Status Priced
Shares Offered 22,000,000
Offer amount $220,000,000
Shares Over Alloted
Company Address 131 CONCORD STREET BROOKLYN NY 11201
Company Phone 3477202907
Company Website www.carislifesciences.com
CEO Mitchell Creem
State of Inc
Fiscal Year End 12-31
Total Offering Expense $575,000.00
Shareholder Shares Offered
Shares Outstanding 27,500,000
Lockup Period (days) 180
Lockup Expiration 2025-12-15 00:00:00
Quiet Period Expiration 2025-07-28 00:00:00
CIK 0002040381
DealId 1337260-114150

Company Description

We are a blank check company incorporated as an exempted company under the laws of the Cayman Islands on August 28, 2024, which will seek to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout this prospectus as our initial business combination. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s and board of director’s background and network, and to capitalize on the ability of our management team and board of directors to identify and acquire a business, focusing on the healthcare or healthcare related industries. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We have generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial business combination. Our management team is comprised of individuals who bring a wealth of experience across diverse domains, including the healthcare sector, financial services, capital markets, special purpose acquisition companies, mergers and acquisitions, private equity, and leadership roles in publicly traded firms. Each member of our team has a robust professional background that spans several decades, and their collective expertise covers a broad spectrum of industries. --- Our executive offices are located at 131 Concord Street, Brooklyn, New York, 11201, and our telephone number is 347-720-2907.